Mechanisms underlying the vascular actions of endothelin 1, angiotensin II and bradykinin in the rat carotid

Pharmacology

Volumn 84, Issue 2, 2009, Pages 111-126

  Tirapelli, Carlos R ^a,c   Bonaventura, Daniella ^b   Tirapelli, Luis F ^c   De Oliveira, Ana M ^b  

^a Department of Psychiatric Nursing and Human Sciences   (Brazil)

^b Faculty of Pharmaceutical Sciences   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Bradykinin; Carotid artery, rat; Endothelin 1

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BRADYKININ; BRADYKININ RECEPTOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR;

ARTERY WALL; CAROTID ARTERY; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANGIOTENSIN II; ANIMALS; BRADYKININ; CAROTID ARTERIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; RATS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; SIGNAL TRANSDUCTION;

EID: 68049100061     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231974     Document Type: Review

References (124)

1. Bonaventura D, Tirapelli CR, Haddad R, Hoehr NF, Eberlin MN, de Oliveira AM: Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II. Pharmacology 2004; 70: 91-99.
2. Accorsi-Mendonça D, Correa FM, Paiva TB, de Souza HP, Laurindo FR, de Oliveira AM: The balloon catheter induces an increase in contralateral carotid artery reactivity to angiotensin II and phenylephrine. Br J Pharmacol 2004; 142: 79-88.
3. B -induced relaxation. Br J Pharmacol 2005; 146: 903-912.
4. Tirapelli CR, Casolari D, Yogi A, Tostes RC, Legros E, Lanchote VL, Uyemura SA, De Oliveira AM: Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol 2007; 41: 77-85.
5. Arribas SM, Daly CJ, González MC, Mc-Grath JC: Imaging the vascular wall using confocal microscopy. J Physiol 2007; 584: 5-9.
6. Wang X, Douglas SA, Louden C, Vickery- Clark LM, Feuerstein GZ, Ohlstein EH: Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin- A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 1996; 78: 322-328.
7. B receptor mRNAs after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1995; 26(suppl 3):S22-S25.
8. Picard P, Smith PJ, Monge JC, Stewart DJ: Expression of endothelial factors after arterial injury in the rat. J Cardiovasc Pharmacol 1998; 31(suppl 1):S323-S327.
9. Loesch A, Milner P, Anglin SC, Crowe R, Miah S, McEwan JR, Burnstock G: Ultrastructural localization of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeiraea simplicifolia ) in the rat carotid artery after balloon catheter injury. J Anat 1997; 190: 93-104.
10. Xavier FE, Yogi A, Callera GE, Tostes RC, Alvarez Y, Salaices M, Alonso MJ, Rossoni LV: Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br J Pharmacol 2004; 143: 794-802.
11. Magder S, Javeshghani D, Cernacek P, Giaid A: Regional distribution of endothelin-1 and endothelin converting enzyme-1 in porcine endotoxemia. Shock 2001; 16: 320-325.
12. Rossi GP, Colonna S, Pavan E, Albertin G, Della Rocca F, Gerosa G, Casarotto D, Sartore S, Pauletto P, Pessina AC: Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo. Circulation 1999; 99: 1147-1155.
13. D'Orléans-Juste P, Plante M, Honoré JC, Carrier E, Labonté J: Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol 2003; 81: 503-510.
14. Bohm F, Johansson BL, Hedin U, Alving K, Pernow J: Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis 2002; 160: 215-222.
15. Zimmermann M, Jung CS, Vatter H, Raabe A, Seifert V: Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery. Acta Neurochir 2002; 144: 1213-1219.
16. Tirapelli CR, Fecteau MH, Honoré JC, Legros E, Gobeil F, D'Orléans-Juste P: Enzymatic pathways involved in the generation of endothelin-1 (1-31) from exogenous big endothelin-1 in the rabbit aorta. Br J Pharmacol 2006; 148: 527-535.
17. Maguire JJ, Johnson CM, Mockridge JW, Davenport AP: Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol 1997; 122: 1647-1654.
18. Hanson GC, Wide-Swenson D, Andersson KE, Lindberg BF: Conversion of big endothelin-1 and characterization of its contractile effects on isolated human placental arteries. Gynecol Obstet Invest 1998; 45: 1-6.
19. B receptor antagonism using BQ-123 and SB 209670. J Cardiovasc Pharmacol 1995; 26(suppl 3):S186- S189.
20. De Oliveira AM, Viswanathan M, Capsoni S, Heemskerk FMJ, Correa FMA, Saavedra JM: Characterization of endothelin A receptors in cerebral and peripheral arteries of the rat. Peptides 1995; 16: 139-144.
21. A receptor expression in rat carotid arteries after balloon injury. Peptides 1997; 18: 247-255.
22. 1 (phylloquinone) induces vascular endothelial dysfunction: role of oxidative stress. Toxicol Appl Pharmacol 2006; 213: 10-17.
23. Sharifi AM, Schiffrin EL: Endothelin receptors mediating vasoconstriction in rat pressurized small arteries. Can J Physiol Pharmacol 1996; 74: 934-939.
24. 2+ mobilization. Mol Cell Biochem 1997; 176: 29-33.
25. B receptors. Mol Cell Biochem 1996; 154: 31-37.
26. B contractile receptors. Eur J Pharmacol 1994; 257: 307-310.
27. Bogoni G, Rizzi A, Calo G, Campobasso C, D'Orleans-Juste P, Regoli D: Characterization of endothelin receptors in the human umbilical artery and vein. Br J Pharmacol 1996; 119: 1600-1604.
28. Sakata K, Ozaki H, Kwon SC, Karaki H: Effects of endothelin on the mechanical activity and cytosolic calcium level of various types of smooth muscle. Br J Pharmacol 1989; 98: 483-492.
29. Luscher TF: Endothelin. J Cardiovasc Pharmacol 1991; 18(suppl 10):S15-S22.
30. De Andrade CR, Leite P, Montezano AC, Casolari D, Yogi A, Tostes R, Hadad R, Eberlin M, Laurindo FRM, Souza HP, Correa FM, de Oliveira AM: Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia. Br J Pharmacol 2009, E-pub ahead of print.
31. Pang DC, Johns A, Patterson K, Botelho LH, Rubanyi GM: Endothelin-1 stimulates phosphatidylinositol hydrolysis and calcium uptake in isolated canine coronary arteries. J Cardiovasc Pharmacol 1989; 13(suppl 5): S75-S79.
32. 2+ store overlaps with caffeine-sensitive one in rat aortic smooth muscle cells in primary cultures. Biochem Biophys Res Commun 1989; 158: 235-243.
33. Wagner Mann C, Bowman L, Sturek M: Primary action of endothelin on Ca release in bovine coronary artery smooth muscle cells. Am J Physiol 1991; 260:C763-C770.
34. De Nucci G, Thomas R, D'Orléans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-8000.
35. Shetty SS, Okada T, Webb RL, Del Grande D, Lappe RW: Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun 1993; 191: 459-464.
36. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohata K, Marumo F: Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993; 91: 1367-1373.
37. Sokolovsky M, Ambar I, Garlon R: A novel subtype of endothelin receptors. J Biol Chem 1992; 267: 20551-20554.
38. Warner TD, De Nucci G, Vane JR: Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 1989; 159: 325-326.
39. Moritoki H, Miyano H, Takeuchi S, Yamaguchi M, Hisayama T, Kondoh W: Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation. Br J Pharmacol 1993; 108: 1125-1130.
40. Emori T, Hirata Y, Marumo F: Endothelin-3 stimulates prostacyclin production in cultured bovine endothelial cells. J Cardiovasc Pharmacol 1991; 17(suppl 7):S140-S142.
41. 2 receptors in mouse abdominal aorta. Braz J Med Biol Res 2007; 40: 649-655.
42. Rakugi H, Nakamaru M, Tabuchi Y, Nagano M, Mikami H, Ogihara T: Endothelin stimulates the release of prostacyclin from rat mesenteric arteries. Biochem Biophys Res Commun 1989; 160: 924-928.
43. D'Orléans-Juste P, Télémaque S, Claing A, Ihara M, Yano M: Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung. Br J Pharmacol 1992; 105: 773-775.
44. D'Orléans-Juste P, Lidbury PS, Télémaque S, Warner TD, Vane JR: Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1. J Cardiovasc Pharmacol 1991; 17(suppl 7):S251-S255.
45. Hasunuma K, Rodman DM, O'Brien RF, McMurty IF: Endothelin-1 causes pulmonary vasodilation in rats. Am J Physiol 1990; 259:H48-H54.
46. Skeggs LT, Lentz KE, Gould AB, Hochstrasser H, Kahn JR: Biochemistry and kinetics of the renin-angiotensin system. Fed Proc 1967; 26: 42-47.
47. Dorer FE, Kahn JR, Lentz KE, Levine M, Skeggs LT: Purification and properties of angiotensin- converting enzyme from hog lung. Circ Res 1972; 31: 356-366.
48. Phillips MI, Speakman EA, Kimura B: Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 1993; 43: 1-20.
49. Inagami T: A memorial to Robert Tiegerstedt: the centennial of renin discovery. Hypertension 1998; 32: 953-957.
50. Hollenberg NK, Fisher NDL, Price DA: Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension 1998; 32: 387-392.
51. Nakamura Y, Nakamura K, Matsukura T, Nakamura K: Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril. J Hypertens 1988; 6: 105-110.
52. Schiffers PM, Struyker-Boudier HA, De Mey JG: Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat. Basic Res Cardiol 1991; 86(suppl 1):83-89.
53. Saavedra JM, Correa FM, Seltzer A, Pinto JE, Viglione P, Tsutsumi K: Enhanced angiotensin converting enzyme binding in arteries from spontaneously hypertensive rats. J Hypertens 1992; 10: 1353-1359.
54. Fernandez-Alfonso MS, Martorana PA, Licka I, van Even P, Trobisch D, Scholkens BA, Paul M: Early induction of angiotensin Iconverting enzyme in rat carotid artery after balloon injury. Hypertension 1997; 30: 272-277.
55. Caputo L, Tedgui A, Lévy BI: Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats: role of endothelium and flow. Circ Res 1995; 77: 303-309.
56. Becari C, Sivieri DO Jr, Santos CF, Moysés MK, Oliveira EB, Salgado MC: Role of elastase-2 as an angiotensin II-forming enzyme in rat carotid artery. J Cardiovasc Pharmacol 2005; 46: 498-504.
57. Paula CA, Sousa MV, Salgado MCO, Oliveira EB: Purification and substrate specificity of an angiotensin converting elastase-2 from the rat mesenteric arterial bed perfusate. Biochim Biophys Acta 1998; 1388: 227-238.
58. Santos CF, Oliveira EB, Salgado MCO, Greene AS: Molecular cloning and sequencing of the cDNA for rat mesenteric arterial bed elastase-2, an angiotensin II-forming enzyme. Can J Physiol Pharmacol 2002; 39: 628-635.
59. Santos CF, Greene AS, Salgado MC, Oliveira EB: Conversion of renin substrate tetradecapeptide to angiotensin II by rat MAB elastase- 2. Can J Physiol Pharmacol 2004; 82: 1000-1005.
60. Shiota N, Okunishi H, Takai S, Mikoshiba I, Sakonjo H, Shibata N, Miyazaki M: Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation 1999; 99: 1084-1090.
61. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T: International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472.
62. Boulanger CM, Caputo L, Lévy BI: Endothelial AT 1 -mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 1995; 26: 752.
63. Kenakin TP: The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes. J Pharmacol Exp Ther 1981; 219: 112-120.
64. Kenakin TP: Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions. Mol Pharmacol 1992; 41: 699-707.
65. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfiel P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-251.
66. Yzydorczyk C, Gobeil F Jr, Cambonie G, Lahaie I, Lê NL, Samarani S, Ahmad A, Lavoie JC, Oligny LL, Pladys P, Hardy P, Nuyt AM: Exaggerated vasomotor response to Ang II in rats with fetal programming of hypertension associated with exposure to a low-protein diet during gestation. Am J Physiol Reg Integ Comp Physiol 2006; 291:R1060-R1068.
67. Barker TA, Massett MP, Korshunov VA, Mohan AM, Kennedy AJ, Berk BC: Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade. Hypertension 2006; 48: 942.
68. 2 receptors and is counterbalanced by nitric oxide. Peptides 2005; 26: 2458-2463.
69. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92: 10663-10667.
70. Hutchinson HG, Hein L, Fujinaga M, Pratt RE: Modulation of vascular development and injury by angiotensin II. Cardiovasc Res 1999; 41: 689-700.
71. Fukada SY, Iyomasa MM, Cunha FQ, Correa FM, de Oliveira AM: Mechanisms of impaired vascular response to Ang II in perivascular injured carotid arteries of ovariectomized rat. J Cardiovasc Pharmacol 2004; 44: 393-400.
72. Wilcox CS, Lin L: Vasoconstrictor prostaglandins and angiotensin- dependent renovascular hypertension. J Nephrol 1993; 6: 124-133.
73. Stanke-Labesque F, Devillier P, Bedouch P, Cracowski JL, Chavanon O, Bessard G: Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition. Cardiovasc Res 2000; 47: 376-383.
74. 2 -receptor modulation of the reactivity to phenylephrine and angiotensin II in the carotid artery of normotensive rats after trandolapril treatment. J Smooth Musc Res 2006; 42: 21-31.
75. Féletou M, Germain M, Teisseire B: Modulation of angiotensin-peptide-induced contraction by the vascular endothelium. J Vasc Med Biol 1990; 2: 18-25.
76. Zhang J, Van Meel JCA, Pfaffendorf M, Zhang J, Van Zwieten PA: Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur J Pharmacol 1994; 262: 247-253.
77. Patel JM, Sekharam KM, Block ER: Angiotensin receptor-mediated stimulation of diacylglycerol production in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1991; 5: 321-327.
78. Guillot FL, Audus KL: Some characteristics of specific angiotensin II binding sites on bovine brain microvessel endothelial cell monolayers. Peptides 1991; 12: 535-540.
79. Yamaguchi K, Nishimura H: Angiotensin IIinduced relaxation of fowl aorta. Am J Physiol 1988; 255:R591-R599.
80. Toda N, Miyazaki M: Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol 1981; 240:H247-H254.
81. 2 receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol 2002; 136: 484-491.
82. Fukada SY, Tirapelli CR, de Godoy MA, de Oliveira AM: Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta. J Cardiovasc Pharmacol 2005; 45: 136-143.
83. 2 receptors mediate vasodepressor response to footshock in rats: role of kinins, nitric oxide and prostaglandins. Eur J Pharmacol 2000; 394: 103-108.
84. Fukada SY, Correa FM, Ramalho LN, Mizusaki CI, de Oliveira AM: Perivascular injury leads to a reduction in vascular reactivity of the collared and to an enhancement on contralateral carotid artery of rats. Cardiovasc Pathol 2004; 13: 251-259.
85. Tirapelli CR, Fukada SY, de Godoy MA, de Oliveira AM: Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid. Life Sci 2006; 78: 2676-2682.
86. Santos RAS, Simões e Silva AC, Maric C, Silva DMR, Machado RP, Buhr I, Heringer- Walther S, Pinheiro SVB, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schulthesis HP, Speth R, Walther T: Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100: 8258-8263.
87. Lemos VS, Silva DM, Walther T, Alenina N, Bader M, Santos RA: The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice. J Cardiovasc Pharmacol 2005; 46: 274-279.
88. Pinheiro SV, Simões e Silva AC, Sampaio WO, de Paula RD, Mendes EP, Bontempo ED, Pesquero JB, Walther T, Alenina N, Bader M, Bleich M, Santes RA: Non-peptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension 2004; 44: 490-496.
89. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM: Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004; 383: 45-51.
90. 1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol 2005; 289: H1013-H1019.
91. Ferrario CM, Barnes KL, Block CH, Brosnihan KB, Diz DI, Khosla MC, Santos RA: Pathways of angiotensin formation and function in the brain. Hypertension 1990; 15: 13-19.
92. 2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol 2004; 141: 860-866.
93. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31: 349-355.
94. Schmaier A, Kuo A, Lundberg D, Murray S, Cines D: The expression of high molecular weight kininogen in human umbilical vein endothelial cells. J Biol Chem 1988; 263: 16327-16333.
95. Oza N, Schwartz J, Gould H, Levinsky N: Rat aortic smooth muscle cells in culture express kallikrein-kininogen and bradykinase activity. J Clin Invest 1990; 85: 597-600.
96. Mahdi F, Shariat-Madar Z, Kuo A, Carinato M, Cines DB, Schmaier AH: Mapping the interaction between high molecular weight kininogen and the urokinase plasminogen activator receptor. J Biol Chem 2004; 279: 16621-16628.
97. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Levy BI, Boulanger CM: Decreased flow-dependent dilation in carotid arteries of tissue-kallikrein- knockout mice. Circ Res 2001; 88: 593-599.
98. Murakami H, Yayama K, Miao RQ, Wang C, Chao L, Chao J: Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty. Hypertension 1999; 34: 164-170.
99. 1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension 2000; 36: 364. 100 Linz W, Wiemer G, Gohlke P, Unger T, Shoelkens BA: Contribution of kinins to the cardiovascular actions of angiotensinconverting enzyme inhibitors. Pharmacol Rev 1995; 47: 25-49.
100. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-Br-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
101. Farhy RD, Ho KL, Carretero OA, Scicli AG: Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1991; 182: 283-288.
102. Gohlke P, Unger T: Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin. Am J Cardiol 1995; 76: 41E-45E.
103. Gardes J, Baussant T, Corvol P, Ménard J, Alhenc-Gelas F: Effect of bradykinin and kininogens in isolated rat kidney vasoconstricted by angiotensin II. Am J Physiol 1990; 258:F1273-F1281.
104. Mombouli JV, Vanhoutte PM: Kinins mediate kallikrein-induced endothelium dependent relaxations in isolated canine coronary arteries. Biochem Biophys Res Commun 1992; 185: 693-697.
105. Regoli D, Barabé J: Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
106. Tirapelli CR, Bonaventura D, de Oliveira AM: Functional characterization of the mechanisms underlying bradykinin-induced relaxation in the isolated rat carotid artery. Life Sci 2007; 80: 1799-1805.
107. Maeda Y, Hirano K, Nishimura J, Sasaki T, Kanaide H: Endothelial dysfunction and altered bradykinin response due to oxidative stress induced by serum deprivation in the bovine cerebral artery. Eur J Pharmacol 2004; 491: 53-60.
108. Zhang RZ, Yang Q, Yim AP, Huang Y, He GW: Different role of nitric oxide and endothelium- derived hyperpolarizing factor in endothelium-dependent hyperpolarization and relaxation in porcine coronary arterial and venous system. J Cardiovasc Pharmacol 2004; 43: 839-850.
109. Raidoo DM, Ramsaroop R, Naidoo S, Muller- Esterl W, Bhoola KD: Kinin receptors in human vascular tissue: their role in atheromatous disease. Immunopharmacology 1997; 36: 153-160.
110. Stewen P, Outi S, Tuulikki N, Frej F: Cyclic AMP increases bradykinin receptor binding affinity in human endothelial cells. Life Sci 2004; 74: 2839-2852.
111. D'Orléans-Juste P, Dion S, Mizrahi J, Regoli D: Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol 1985; 114: 9-21.
112. Regoli D, Pheng LH, Allogho SN, Nguyen- Le XK, Gobeil F: Receptors for kinins: from classical pharmacology to molecular biology. Immunopharmacology 1996; 33: 116- 122.
113. Gambillara V, Chambaz C, Montorzi G, Roy S, Stergiopulos N, Silacci P: Plaqueprone hemodynamics impair endothelial function in pig carotid arteries. Am J Physiol Heart Circ Physiol 2006; 290:H2320-H2328.
114. Cherry P, Furchgott R, Zawadzki J, Jothianandan D: Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 1982; 79: 2106-2110.
115. Wiemer G, Scholkens BA, Becker RH, Busse R: Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991; 18: 558-563.
116. Barrow SE, Dollery CT, Heavey DJ, Hickling NE, Ritter JM, Mial J: Effect of vasoactive peptides on prostacyclin synthesis in man. Br J Pharmacol 1986; 87: 243-247.
117. Chapnick BM, Paustian PW, Feigen LP, Joiner PD, Hyman AL, Kadowitz PJ: Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the cat. Circ Res 1977; 40: 348-354.
118. Regoli DC, Marceau F, Lavigne J: Induction of B 1 receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol 1981; 71: 105-115.
119. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F: Induction of endothelin- 1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19: 753-757.
120. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F: Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 1991; 18: 165-170.
121. d'Uscio LV, Shaw S, Barton M, Luscher T: Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase. Hypertension 1998; 31: 1305-1310.
122. Kawaguchi H, Sawa H, Yasuda H: Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. J Mol Cell Cardiol 1990; 22: 839-842.
123. Webb ML, Dickinson KEJ, Delaney CL, Liu EC-K, Serafino R, Cohen RB, Monshizadegan H, Moreland S: The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochem Biophys Res Commun 1992; 185: 887-892.
124. Wenzel RR, Ruthermann J, Bruck H, Schafers RF, Michel MC, Philipp TH: Endothelin- A receptor antagonist inhibits angiotensin II and noradrenalin in man. Br J Clin Pharmacol 2001; 52: 151-157.